ArticleWorld journal of nephrology2026
Metabolic evaluation in first time and recurrent urinary stone formers: Study from a tertiary care center of India.
Article in World journal of nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney stone disease is a common and often debilitating disorder with significant recurrence rate. It is a matter of debate whether the metabolic factors responsible for renal stone formation are similar or variable in different populations around the globe.
aimTo evaluate the metabolic abnormalities
methodsThis retrospective study was conducted at a tertiary care center between 2022 and 2024 and included 70 patients with urolithiasis, comprising 30 first-time stone formers and 40 recurrent stone formers (RSF). All patients underwent biochemical evaluation, including serum calcium, phosphorus, uric acid, creatinine, and intact parathyroid hormone levels. A 24-hour urine analysis was performed to assess urinary volume and the excretion of calcium, oxalate, citrate, uric acid, and phosphate. Metabolic abnormalities were defined according to standard criteria. Statistical analysis was performed using the independent
resultsFifty-nine patients (84.2%) had at least one identifiable metabolic risk factor, with 37 patients (52.8%) having two or more metabolic abnormalities. The most common abnormalities detected were hypercalciuria 27 (38.5%) and hyper-oxaluria 19 (27.1%). Low urine volume, hypocitraturia and hyperuricemia was seen in 14 (20%), 16 (22.8%) and 4 (5.7%) patients respectively. Primary hyperparathyroidism was seen in a total of 8 (11.4%) patients. Metabolic abnormalities were seen more commonly in RSF but there was no statistically significant difference (
conclusionMetabolic evaluation reveals they were prevalent in > 70% of both groups, supporting routine evaluation even in first-time formers in high-risk regions. Hypocitraturia, hyperoxaluria, hyperphosphatemia and hyperparathyroidism are present in a significant proportion of Indian stone former patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.